Antibiotic use for inpatient newborn care with suspected infection: EN-BIRTH multi-country validation study
-
Published:2021-03
Issue:S1
Volume:21
Page:
-
ISSN:1471-2393
-
Container-title:BMC Pregnancy and Childbirth
-
language:en
-
Short-container-title:BMC Pregnancy Childbirth
Author:
Rahman Ahmed Ehsanur, ,Hossain Aniqa Tasnim,Zaman Sojib Bin,Salim Nahya,K.C. Ashish,Day Louise T.,Ameen Shafiqul,Ruysen Harriet,Kija Edward,Peven Kimberly,Tahsina Tazeen,Ahmed Anisuddin,Rahman Qazi Sadeq-ur,Khan Jasmin,Kong Stefanie,Campbell Harry,Hailegebriel Tedbabe Degefie,Ram Pavani K.,Qazi Shamim A.,El Arifeen Shams,Lawn Joy E.
Abstract
Abstract
Background
An estimated 30 million neonates require inpatient care annually, many with life-threatening infections. Appropriate antibiotic management is crucial, yet there is no routine measurement of coverage. The Every Newborn Birth Indicators Research Tracking in Hospitals (EN-BIRTH) study aimed to validate maternal and newborn indicators to inform measurement of coverage and quality of care. This paper reports validation of reported antibiotic coverage by exit survey of mothers for hospitalized newborns with clinically-defined infections, including sepsis, meningitis, and pneumonia.
Methods
EN-BIRTH study was conducted in five hospitals in Bangladesh, Nepal, and Tanzania (July 2017–July 2018). Neonates were included based on case definitions to focus on term/near-term, clinically-defined infection syndromes (sepsis, meningitis, and pneumonia), excluding major congenital abnormalities. Clinical management was abstracted from hospital inpatient case notes (verification) which was considered as the gold standard against which to validate accuracy of women’s report. Exit surveys were conducted using questions similar to The Demographic and Health Surveys (DHS) approach for coverage of childhood pneumonia treatment. We compared survey-report to case note verified, pooled across the five sites using random effects meta-analysis.
Results
A total of 1015 inpatient neonates admitted in the five hospitals met inclusion criteria with clinically-defined infection syndromes. According to case note verification, 96.7% received an injectable antibiotic, although only 14.5% of them received the recommended course of at least 7 days. Among women surveyed (n = 910), 98.8% (95% CI: 97.8–99.5%) correctly reported their baby was admitted to a neonatal ward. Only 47.1% (30.1–64.5%) reported their baby’s diagnosis in terms of sepsis, meningitis, or pneumonia. Around three-quarters of women reported their baby received an injection whilst in hospital, but 12.3% reported the correct antibiotic name. Only 10.6% of the babies had a blood culture and less than 1% had a lumbar puncture.
Conclusions
Women’s report during exit survey consistently underestimated the denominator (reporting the baby had an infection), and even more so the numerator (reporting known injectable antibiotics). Admission to the neonatal ward was accurately reported and may have potential as a contact point indicator for use in household surveys, similar to institutional births. Strengthening capacity and use of laboratory diagnostics including blood culture are essential to promote appropriate use of antibiotics. To track quality of neonatal infection management, we recommend using inpatient records to measure specifics, requiring more research on standardised inpatient records.
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology
Reference72 articles.
1. Lawn JE, Blencowe H, Oza S, You D, Lee AC, Waiswa P, Lalli M, Bhutta Z, Barros AJ, Christian P. Every newborn: progress, priorities, and potential beyond survival. Lancet. 2014;384(9938):189–205. 2. WHO: Newborn death and illness. https://www.who.int/pmnch/media/press_materials/fs/fs_newborndealth_illness/en/. Accessed 17 Sept 2020. 3. UNICEF, WHO, World Bank Group, United Nations: Levels & Trends in Child Mortality- Report 2020: Estimates developed by the UN Inter-agency Group for Child Mortality Estimation. https://childmortality.org/wp-content/uploads/2015/10/Levels-and-Trends-in-Child-Mortality-Report-2015.pdf. Accessed 17 Sept 2020. 4. Saha SK, Schrag SJ, El Arifeen S, Mullany LC, Islam MS, Shang N, Qazi SA, Zaidi AK, Bhutta ZA, Bose A. Causes and incidence of community-acquired serious infections among young children in South Asia (ANISA): an observational cohort study. Lancet. 2018;392(10142):145–59. 5. Rahman AE, Herrera S, Rubayet S, Banik G, Hasan R, Ahsan Z, Siraj W, Ahmed A, Siddique AB, Rahman QS. Managing possible serious bacterial infection of young infants where referral is not possible: lessons from the early implementation experience in Kushtia District learning laboratory, Bangladesh. PLoS One. 2020;15(5):e0232675.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|